Lanean...
STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
Gorde:
Egile nagusia: | |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Saila: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Gaiak: | |
Sarrera elektronikoa: | https://www.rpcardio.com/jour/article/view/192 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|